Neisseria meningitidis; clones, carriage, and disease

Clinical Microbiology and Infection

Volumn 20, Issue 5, 2014, Pages 391-395

  Read, R C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Clonal complexes; Molecular epidemiology; Neisseria meningitidis; Serogroup; Vaccine

Indexed keywords

ARTICLE; BACTERIUM CARRIER; CLONE; ECOLOGICAL NICHE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; LONGEVITY; MENINGOCOCCOSIS; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; BACTERIAL GENOME; BACTERIUM IDENTIFICATION; CLASSIFICATION; EPIDEMIC; GENETICS; HETEROZYGOTE; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; NASOPHARYNX; SEROTYPE;

BACTERIAL TYPING TECHNIQUES; CARRIER STATE; EPIDEMICS; GENOME, BACTERIAL; HUMANS; MENINGOCOCCAL INFECTIONS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NASOPHARYNX; NEISSERIA MENINGITIDIS; PHENOTYPE; SEROGROUP;

EID: 84901505870     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12647     Document Type: Review

References (24)

1. Jafri RZ, Ali A, Messonnier NE et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr 2013; 11: 17-26.
2. Ala'aldeen DA, Oldfield NJ, Bidmos FA et al. Carriage of meningococci by university students, United Kingdom. Emerg Infect Dis 2011; 17: 1762-1763.
3. Caugant DA, Tzanakaki G, Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol Rev 2007; 31: 52-63.
4. Giuliani MM, Adu-Bobie J, Comanducci M et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci USA 2006; 103: 10834-10839.
5. Trotter CL, Chandra M, Cano R et al. A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev 2007; 31: 27-36.
6. Read RC, Cannings C, Naylor SC et al. Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease. Ann Intern Med 2003; 138: 534-541.
7. von Gottberg A, du Plessis M, Cohen C et al. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis 2008; 46: 377-386.
8. Maiden MC, Bygraves JA, Feil E et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95: 3140-3145.
9. Jolley KA, Maiden MC. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 2010; 11: 595-606.
10. Zhou J, Spratt BG. Sequence diversity within the argF, fbp and recA genes of natural isolates of Neisseria meningitidis: interspecies recombination within the argF gene. Mol Microbiol 1992; 6: 2135-2146.
11. Yazdankhah SP, Kriz P, Tzanakaki G et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 2004; 42: 5146-5153.
12. Frosch M, Weisgerber C, Meyer TF. Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Natl Acad Sci USA 1989; 86: 1669-1673.
13. Harrison OB, Claus H, Jiang Y et al. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis 2013; 19: 566-573.
14. Claus H, Maiden MC, Maag R, Frosch M, Vogel U. Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 2002; 148: 1813-1819.
15. Caugant DA, Maiden MC. Meningococcal carriage and disease-population biology and evolution. Vaccine 2009; 27(suppl 2): B64-B70.
16. Holmes EC, Urwin R, Maiden MC. The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis. Mol Biol Evol 1999; 16: 741-749.
17. Jolley KA, Kalmusova J, Feil EJ et al. Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol 2000; 38: 4492-4498.
18. Urwin R, Russell JE, Thompson EA, Holmes EC, Feavers IM, Maiden MC. Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun 2004; 72: 5955-5962.
19. Ibarz-Pavón AB, Maclennan J, Andrews NJ et al. Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis 2011; 204: 1046-1053.
20. Schoen C, Blom J, Claus H et al. Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci USA 2008; 105: 3473-3478.
21. Watkins ER, Maiden MC. Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database. PLoS ONE 2012; 7: e45349.
22. Caugant DA, Nicolas P. Molecular surveillance of meningococcal meningitis in Africa. Vaccine 2007; 3(25 suppl 1): A8-A11.
23. Mandal S, Wu HM, MacNeil JR et al. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States. Clin Infect Dis. 2013; 57: 344-348.
24. Zhou JS, Lefebvre B, Deng S et al. Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003. J Clin Microbiol. 2012; 50: 1545-1551.